Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
Immunol Rev. 2024 Jul;324(1):52-67. doi: 10.1111/imr.13336. Epub 2024 Apr 26.
Regulatory T cells (Tregs) within the visceral adipose tissue (VAT) play a crucial role in controlling tissue inflammation and maintaining metabolic health. VAT Tregs display a unique transcriptional profile and T cell receptor (TCR) repertoire, and closely interact with adipocytes, stromal cells, and other immune components within the local VAT microenvironment. However, in the context of obesity, there is a notable decline in VAT Tregs, resulting in heightened VAT inflammation and insulin resistance. A comprehensive understanding of the biology of VAT Tregs is essential for the development of Treg-based therapies for mitigating obesity-associated metabolic diseases. Recent advancements in lineage tracing tools, genetic mouse models, and various single cell "omics" techniques have significantly progressed our understandings of the origin, differentiation, and regulation of this unique VAT Treg population at steady state and during obesity. The identification of VAT-Treg precursor cells in the secondary lymphoid organs has also provided important insights into the timing, location, and mechanisms through which VAT Tregs acquire their distinctive phenotype that enables them to function within a lipid-rich microenvironment. In this review, we highlight key recent breakthroughs in the VAT-Treg field while discussing pivotal questions that remain unanswered.
内脏脂肪组织(VAT)中的调节性 T 细胞(Tregs)在控制组织炎症和维持代谢健康方面发挥着关键作用。VAT Tregs 表现出独特的转录谱和 T 细胞受体(TCR)库,并且与脂肪细胞、基质细胞和局部 VAT 微环境中的其他免疫成分密切相互作用。然而,在肥胖的情况下,VAT Tregs 明显减少,导致 VAT 炎症和胰岛素抵抗加剧。全面了解 VAT Tregs 的生物学特性对于开发基于 Treg 的疗法以减轻肥胖相关代谢疾病至关重要。谱系追踪工具、遗传小鼠模型和各种单细胞“组学”技术的最新进展极大地促进了我们对稳态和肥胖期间这种独特的 VAT Treg 群体的起源、分化和调控的理解。在次级淋巴器官中鉴定出 VAT-Treg 前体细胞,也为 VAT Tregs 获得使其能够在富含脂质的微环境中发挥功能的独特表型的时间、位置和机制提供了重要的见解。在这篇综述中,我们强调了 VAT-Treg 领域的最新重大突破,同时讨论了仍未解答的关键问题。